Agenda - Council - 03/25/1997 - Laserfiche WebLink

Home

I I I I I I I I I I I I I I I Above, goats vie for attention as they stare across the farm. maintenance facility and a dairy facility, "Our dairy facility is designed to be the state-of-the-art pilot facility for pharmaceutical dairying," Smith states. "I'd like to qualify dairying to mean the endpoint of the milk that is harvested is destined for pharmaceutical purification, not. consumption." Because of the pharmaceutical nature, Genzyme must be concerned with the FDA's rules and regulations regarding animals, rather than those of the United States Department of Agriculture. "\Ve had to take a good hard look," begins Smith, "at i~conventionai dairy practices and building design and combine those with the pharmaceutical elements. Essentially, what we have developed is a twin dairy arrangement all under one roof. What the building consists of is a dairy on the north wing and a dairy on the south wing. These are back-to-back mirror image facilities. We built our buildings as a result of the need to houa~ a very unique population of animals. These were animals we imported from New Zealand because of their disease freedom. We have a valuable herd of animals that potentially have the ability to produce a lifesaving pharmaceutical in their milk. Consequently, we needed to maintain these disease-free animals in a microcosm." With the number of buildings Genzyme has purchased from Morton Buildings, it seems they have found a trusted fl'iend. "[The people at] Morton Buildings are great." declares Smith. "We couldn't be happier. We're planning on a sixth and potentially a seventh [building]. As well as extensions on some existing buildings."